US6010613A
(en)
*
|
1995-12-08 |
2000-01-04 |
Cyto Pulse Sciences, Inc. |
Method of treating materials with pulsed electrical fields
|
EP0938674B1
(en)
|
1996-11-16 |
2005-06-01 |
NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen in Reutlingen Stiftung Bürgerlichen Rechts |
Array of microelements, method of contacting cells in a liquid environment and method for the production of an array of microelements
|
EP1003847A4
(en)
*
|
1997-09-04 |
2005-04-06 |
Science Res Lab Inc |
Cell separation using electric fields
|
WO1999042156A1
(en)
|
1998-02-24 |
1999-08-26 |
Boston Scientific Limited |
High flow rate dialysis catheters and related methods
|
DE19841337C1
(en)
|
1998-05-27 |
1999-09-23 |
Micronas Intermetall Gmbh |
Intracellular manipulation of biological cell contents, assisting injection or removal of substances or cell components
|
DE19827957C2
(en)
*
|
1998-05-27 |
2000-06-29 |
Micronas Intermetall Gmbh |
Method and device for measuring a state variable
|
GB9812519D0
(en)
*
|
1998-06-10 |
1998-08-05 |
Immunoporation Ltd |
Treating cells
|
WO1999064581A1
(en)
|
1998-06-10 |
1999-12-16 |
University Of South Florida |
Electrofusion chamber
|
GB9812783D0
(en)
*
|
1998-06-12 |
1998-08-12 |
Cenes Ltd |
High throuoghput screen
|
AU5122499A
(en)
|
1998-07-27 |
2000-02-21 |
Genentech Inc. |
Improved transformation efficiency in phage display through modification of a coat protein
|
GB9908681D0
(en)
*
|
1999-04-16 |
1999-06-09 |
Central Research Lab Ltd |
Apparatus for, and method of, introducing a substance into an object
|
US7053063B2
(en)
*
|
1999-07-21 |
2006-05-30 |
The Regents Of The University Of California |
Controlled electroporation and mass transfer across cell membranes in tissue
|
US6403348B1
(en)
*
|
1999-07-21 |
2002-06-11 |
The Regents Of The University Of California |
Controlled electroporation and mass transfer across cell membranes
|
US6300108B1
(en)
*
|
1999-07-21 |
2001-10-09 |
The Regents Of The University Of California |
Controlled electroporation and mass transfer across cell membranes
|
US6387671B1
(en)
|
1999-07-21 |
2002-05-14 |
The Regents Of The University Of California |
Electrical impedance tomography to control electroporation
|
US6927049B2
(en)
*
|
1999-07-21 |
2005-08-09 |
The Regents Of The University Of California |
Cell viability detection using electrical measurements
|
AU2001228841A1
(en)
*
|
2000-01-27 |
2001-08-07 |
The Mollennium Laboratories |
Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method
|
US6697670B2
(en)
*
|
2001-08-17 |
2004-02-24 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients
|
US8251986B2
(en)
|
2000-08-17 |
2012-08-28 |
Angiodynamics, Inc. |
Method of destroying tissue cells by eletroporation
|
US6892099B2
(en)
|
2001-02-08 |
2005-05-10 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation
|
US6795728B2
(en)
|
2001-08-17 |
2004-09-21 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits by electroporation
|
US6994706B2
(en)
*
|
2001-08-13 |
2006-02-07 |
Minnesota Medical Physics, Llc |
Apparatus and method for treatment of benign prostatic hyperplasia
|
USRE42016E1
(en)
|
2001-08-13 |
2010-12-28 |
Angiodynamics, Inc. |
Apparatus and method for the treatment of benign prostatic hyperplasia
|
US7130697B2
(en)
*
|
2002-08-13 |
2006-10-31 |
Minnesota Medical Physics Llc |
Apparatus and method for the treatment of benign prostatic hyperplasia
|
DE60226501D1
(en)
*
|
2001-08-31 |
2008-06-19 |
Cyto Pulse Sciences Inc |
DIELECTROPHORESE WAVEFORM WITH NONLINEAR AMPLITUDE FOR CELL FUSION
|
US6713292B2
(en)
*
|
2001-12-06 |
2004-03-30 |
Bio-Rad Laboratories, Inc. |
Electroporation cuvette insert for facilitating membrane-based fusion
|
DE10202094B4
(en)
|
2002-01-21 |
2006-09-28 |
Eppendorf Ag |
Method and device for electroporation of biological cells
|
ATE364077T1
(en)
*
|
2002-02-22 |
2007-06-15 |
Idm Immuno Designed Molecules |
METHOD FOR ELECTROFUSION OF CELLS
|
KR100859715B1
(en)
*
|
2002-07-16 |
2008-09-23 |
독립행정법인농업생물자원연구소 |
Device for electroporation including the use of depressurization/pressurization
|
ES2375724T3
(en)
|
2002-09-27 |
2012-03-05 |
The General Hospital Corporation |
MICROFLUDE DEVICE FOR SEPERATION OF CELLS AND ITS USES.
|
EP1565555A4
(en)
*
|
2002-09-30 |
2008-07-09 |
Maxcyte Inc |
Apparatus and method for streaming electroporation
|
US8298222B2
(en)
*
|
2003-12-24 |
2012-10-30 |
The Regents Of The University Of California |
Electroporation to deliver chemotherapeutics and enhance tumor regression
|
PL1696812T3
(en)
|
2003-12-24 |
2015-12-31 |
Univ California |
Tissue ablation with irreversible electroporation
|
JP4443278B2
(en)
*
|
2004-03-26 |
2010-03-31 |
テルモ株式会社 |
Catheter with expansion body
|
EP1789453A2
(en)
*
|
2004-05-18 |
2007-05-30 |
Genentech, Inc. |
M13 virus major coat protein variants for c-terminal and bi-terminal display of a heterologous protein
|
JPWO2006098430A1
(en)
*
|
2005-03-17 |
2008-08-28 |
富士フイルム株式会社 |
Intracellular substance introduction device, cell clamping device and flow path forming method
|
US20070196820A1
(en)
|
2005-04-05 |
2007-08-23 |
Ravi Kapur |
Devices and methods for enrichment and alteration of cells and other particles
|
US20060264752A1
(en)
*
|
2005-04-27 |
2006-11-23 |
The Regents Of The University Of California |
Electroporation controlled with real time imaging
|
US20060281168A1
(en)
*
|
2005-06-13 |
2006-12-14 |
Tosoh Corporation |
Cell fusion chamber, cell fusion device, and method for cell fusion using the same
|
US20060293725A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Boris Rubinsky |
Methods and systems for treating fatty tissue sites using electroporation
|
US20060293731A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Boris Rubinsky |
Methods and systems for treating tumors using electroporation
|
US20060293730A1
(en)
|
2005-06-24 |
2006-12-28 |
Boris Rubinsky |
Methods and systems for treating restenosis sites using electroporation
|
US8114070B2
(en)
|
2005-06-24 |
2012-02-14 |
Angiodynamics, Inc. |
Methods and systems for treating BPH using electroporation
|
EP1908057B1
(en)
*
|
2005-06-30 |
2012-06-20 |
LG Electronics Inc. |
Method and apparatus for decoding an audio signal
|
US8921102B2
(en)
|
2005-07-29 |
2014-12-30 |
Gpb Scientific, Llc |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
US20070105206A1
(en)
*
|
2005-10-19 |
2007-05-10 |
Chang Lu |
Fluidic device
|
US20070156135A1
(en)
*
|
2006-01-03 |
2007-07-05 |
Boris Rubinsky |
System and methods for treating atrial fibrillation using electroporation
|
EP2076313A4
(en)
|
2006-10-16 |
2012-07-25 |
Univ California |
Gels with predetermined conductivity used in irreversible electroporation of tissue
|
US20080132884A1
(en)
*
|
2006-12-01 |
2008-06-05 |
Boris Rubinsky |
Systems for treating tissue sites using electroporation
|
EP3190178A1
(en)
|
2007-02-23 |
2017-07-12 |
Astellas Institute for Regenerative Medicine |
Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells
|
US20100004623A1
(en)
*
|
2008-03-27 |
2010-01-07 |
Angiodynamics, Inc. |
Method for Treatment of Complications Associated with Arteriovenous Grafts and Fistulas Using Electroporation
|
WO2009121017A1
(en)
|
2008-03-27 |
2009-10-01 |
The Regents Of The University Of California |
Balloon catheter for reducing restenosis via irreversible electroporation
|
US9867652B2
(en)
|
2008-04-29 |
2018-01-16 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
|
US8992517B2
(en)
|
2008-04-29 |
2015-03-31 |
Virginia Tech Intellectual Properties Inc. |
Irreversible electroporation to treat aberrant cell masses
|
US9198733B2
(en)
|
2008-04-29 |
2015-12-01 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for electroporation-based therapies
|
US10272178B2
(en)
|
2008-04-29 |
2019-04-30 |
Virginia Tech Intellectual Properties Inc. |
Methods for blood-brain barrier disruption using electrical energy
|
US10702326B2
(en)
|
2011-07-15 |
2020-07-07 |
Virginia Tech Intellectual Properties, Inc. |
Device and method for electroporation based treatment of stenosis of a tubular body part
|
US11272979B2
(en)
|
2008-04-29 |
2022-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
US11254926B2
(en)
|
2008-04-29 |
2022-02-22 |
Virginia Tech Intellectual Properties, Inc. |
Devices and methods for high frequency electroporation
|
US10117707B2
(en)
|
2008-04-29 |
2018-11-06 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
WO2009134876A1
(en)
|
2008-04-29 |
2009-11-05 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation to create tissue scaffolds
|
US10238447B2
(en)
|
2008-04-29 |
2019-03-26 |
Virginia Tech Intellectual Properties, Inc. |
System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
|
US9283051B2
(en)
|
2008-04-29 |
2016-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating a treatment volume for administering electrical-energy based therapies
|
US10245098B2
(en)
|
2008-04-29 |
2019-04-02 |
Virginia Tech Intellectual Properties, Inc. |
Acute blood-brain barrier disruption using electrical energy based therapy
|
US20090281477A1
(en)
|
2008-05-09 |
2009-11-12 |
Angiodynamics, Inc. |
Electroporation device and method
|
US9173704B2
(en)
|
2008-06-20 |
2015-11-03 |
Angiodynamics, Inc. |
Device and method for the ablation of fibrin sheath formation on a venous catheter
|
US9681909B2
(en)
|
2008-06-23 |
2017-06-20 |
Angiodynamics, Inc. |
Treatment devices and methods
|
US20100152725A1
(en)
*
|
2008-12-12 |
2010-06-17 |
Angiodynamics, Inc. |
Method and system for tissue treatment utilizing irreversible electroporation and thermal track coagulation
|
WO2010085765A2
(en)
|
2009-01-23 |
2010-07-29 |
Moshe Meir H |
Therapeutic energy delivery device with rotational mechanism
|
WO2010093692A2
(en)
|
2009-02-10 |
2010-08-19 |
Hobbs Eamonn P |
Irreversible electroporation and tissue regeneration
|
WO2010118387A1
(en)
|
2009-04-09 |
2010-10-14 |
Virginia Tech Intellectual Properties, Inc. |
Integration of very short electric pulses for minimally to noninvasive electroporation
|
US11638603B2
(en)
|
2009-04-09 |
2023-05-02 |
Virginia Tech Intellectual Properties, Inc. |
Selective modulation of intracellular effects of cells using pulsed electric fields
|
US11382681B2
(en)
|
2009-04-09 |
2022-07-12 |
Virginia Tech Intellectual Properties, Inc. |
Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
|
USD630321S1
(en)
|
2009-05-08 |
2011-01-04 |
Angio Dynamics, Inc. |
Probe handle
|
US8903488B2
(en)
|
2009-05-28 |
2014-12-02 |
Angiodynamics, Inc. |
System and method for synchronizing energy delivery to the cardiac rhythm
|
US9895189B2
(en)
|
2009-06-19 |
2018-02-20 |
Angiodynamics, Inc. |
Methods of sterilization and treating infection using irreversible electroporation
|
US20110118732A1
(en)
|
2009-11-19 |
2011-05-19 |
The Regents Of The University Of California |
Controlled irreversible electroporation
|
US9816086B2
(en)
*
|
2010-07-06 |
2017-11-14 |
The Ohio State University |
Dose and location controlled drug/gene/particle delivery to individual cells by nanoelectroporation
|
WO2012051433A2
(en)
|
2010-10-13 |
2012-04-19 |
Angiodynamics, Inc. |
System and method for electrically ablating tissue of a patient
|
WO2012088149A2
(en)
|
2010-12-20 |
2012-06-28 |
Virginia Tech Intellectual Properties, Inc. |
High-frequency electroporation for cancer therapy
|
US9382510B2
(en)
|
2011-08-25 |
2016-07-05 |
Jian Chen |
Methods and devices for electroporation
|
US9078665B2
(en)
|
2011-09-28 |
2015-07-14 |
Angiodynamics, Inc. |
Multiple treatment zone ablation probe
|
US9414881B2
(en)
|
2012-02-08 |
2016-08-16 |
Angiodynamics, Inc. |
System and method for increasing a target zone for electrical ablation
|
US9888956B2
(en)
|
2013-01-22 |
2018-02-13 |
Angiodynamics, Inc. |
Integrated pump and generator device and method of use
|
US10166321B2
(en)
|
2014-01-09 |
2019-01-01 |
Angiodynamics, Inc. |
High-flow port and infusion needle systems
|
CN112807074A
(en)
|
2014-05-12 |
2021-05-18 |
弗吉尼亚暨州立大学知识产权公司 |
Electroporation system
|
KR102617137B1
(en)
|
2014-09-15 |
2023-12-27 |
칠드런'즈 메디컬 센터 코포레이션 |
Methods and compositions to increase somatic cell nuclear transfer (scnt) efficiency by removing histone h3-lysine trimethylation
|
US10694972B2
(en)
|
2014-12-15 |
2020-06-30 |
Virginia Tech Intellectual Properties, Inc. |
Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
|
US10660691B2
(en)
|
2015-10-07 |
2020-05-26 |
Angiodynamics, Inc. |
Multiple use subassembly with integrated fluid delivery system for use with single or dual-lumen peristaltic tubing
|
US11390840B2
(en)
*
|
2016-09-30 |
2022-07-19 |
University Of Florida Research Foundation, Inc. |
Systems and methods including porous membrane for low-voltage continuous cell electroporation
|
US10905492B2
(en)
|
2016-11-17 |
2021-02-02 |
Angiodynamics, Inc. |
Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
|
US11043823B2
(en)
*
|
2017-04-06 |
2021-06-22 |
Tesla, Inc. |
System and method for facilitating conditioning and testing of rechargeable battery cells
|
EP3710576A1
(en)
|
2017-11-17 |
2020-09-23 |
Iovance Biotherapeutics, Inc. |
Til expansion from fine needle aspirates and small biopsies
|
CA3083118A1
(en)
|
2017-11-22 |
2019-05-31 |
Iovance Biotherapeutics, Inc. |
Expansion of peripheral blood lymphocytes (pbls) from peripheral blood
|
US11607537B2
(en)
|
2017-12-05 |
2023-03-21 |
Virginia Tech Intellectual Properties, Inc. |
Method for treating neurological disorders, including tumors, with electroporation
|
US11311329B2
(en)
|
2018-03-13 |
2022-04-26 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
|
US11925405B2
(en)
|
2018-03-13 |
2024-03-12 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning system for immunotherapy enhancement via non-thermal ablation
|
KR20210005138A
(en)
|
2018-04-27 |
2021-01-13 |
이오반스 바이오테라퓨틱스, 인크. |
Closure method for expansion and gene editing of tumor infiltrating lymphocytes and their use in immunotherapy
|
IT201800006914A1
(en)
*
|
2018-07-04 |
2020-01-04 |
|
ELECTRICAL CHARACTERIZATION DEVICE FOR CELLULAR BUILDINGS
|
JP2022506586A
(en)
|
2018-11-05 |
2022-01-17 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
Process for the production of tumor-infiltrating lymphocytes and their use in immunotherapy
|
KR20210099573A
(en)
|
2018-11-05 |
2021-08-12 |
이오반스 바이오테라퓨틱스, 인크. |
Selection of improved tumor-reactive T-cells
|
KR20210091212A
(en)
|
2018-11-05 |
2021-07-21 |
이오반스 바이오테라퓨틱스, 인크. |
Treatment of NSCLC Patients Refractory to Anti-PD-1 Antibodies
|
CA3118493A1
(en)
|
2018-11-05 |
2020-05-14 |
Iovance Biotherapeutics, Inc. |
Expansion of tils utilizing akt pathway inhibitors
|
CA3123392A1
(en)
|
2018-12-19 |
2020-06-25 |
Iovance Biotherapeutics, Inc. |
Methods of expanding tumor infiltrating lymphocytes using engineered cytokine receptor pairs and uses thereof
|
KR20210136050A
(en)
|
2019-03-01 |
2021-11-16 |
이오반스 바이오테라퓨틱스, 인크. |
Expansion of tumor-infiltrating lymphocytes from liquid tumors and their therapeutic use
|
WO2020232029A1
(en)
|
2019-05-13 |
2020-11-19 |
Iovance Biotherapeutics, Inc. |
Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
US11950835B2
(en)
|
2019-06-28 |
2024-04-09 |
Virginia Tech Intellectual Properties, Inc. |
Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
|
EP4048295A1
(en)
|
2019-10-25 |
2022-08-31 |
Iovance Biotherapeutics, Inc. |
Gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
JP2023506734A
(en)
|
2019-12-11 |
2023-02-20 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
Process for the production of tumor-infiltrating lymphocytes (TIL) and methods of using same
|
JP2023523855A
(en)
|
2020-05-04 |
2023-06-07 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
Method for producing tumor-infiltrating lymphocytes and their use in immunotherapy
|
EP4225330A1
(en)
|
2020-10-06 |
2023-08-16 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
WO2022076606A1
(en)
|
2020-10-06 |
2022-04-14 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
JP2023554395A
(en)
|
2020-12-17 |
2023-12-27 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
Treatment with tumor-infiltrating lymphocyte therapy in combination with CTLA-4 and PD-1 inhibitors
|
WO2022133149A1
(en)
|
2020-12-17 |
2022-06-23 |
Iovance Biotherapeutics, Inc. |
Treatment of cancers with tumor infiltrating lymphocytes
|
WO2022165260A1
(en)
|
2021-01-29 |
2022-08-04 |
Iovance Biotherapeutics, Inc. |
Methods of making modified tumor infiltrating lymphocytes and their use in adoptive cell therapy
|
CA3212439A1
(en)
|
2021-03-19 |
2022-09-22 |
Michelle SIMPSON-ABELSON |
Methods for tumor infiltrating lymphocyte (til) expansion related to cd39/cd69 selection and gene knockout in tils
|
CA3213080A1
(en)
|
2021-03-23 |
2022-09-29 |
Krit RITTHIPICHAI |
Cish gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
KR20240037185A
(en)
|
2021-04-19 |
2024-03-21 |
이오반스 바이오테라퓨틱스, 인크. |
Chimeric costimulatory receptors, chemokine receptors, and their uses in cellular immunotherapy
|
EP4340850A1
(en)
|
2021-05-17 |
2024-03-27 |
Iovance Biotherapeutics, Inc. |
Pd-1 gene-edited tumor infiltrating lymphocytes and uses of same in immunotherapy
|
CA3226111A1
(en)
|
2021-07-22 |
2023-01-26 |
Iovance Biotherapeutics, Inc. |
Method for cryopreservation of solid tumor fragments
|
WO2023009716A1
(en)
|
2021-07-28 |
2023-02-02 |
Iovance Biotherapeutics, Inc. |
Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with kras inhibitors
|
AU2022343729A1
(en)
|
2021-09-09 |
2024-03-21 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products using pd-1 talen knockdown
|
AR127482A1
(en)
|
2021-10-27 |
2024-01-31 |
Iovance Biotherapeutics Inc |
SYSTEMS AND METHODS TO COORDINATE THE MANUFACTURE OF CELLS FOR PATIENT-SPECIFIC IMMUNOTHERAPY
|
WO2023086803A1
(en)
|
2021-11-10 |
2023-05-19 |
Iovance Biotherapeutics, Inc. |
Methods of expansion treatment utilizing cd8 tumor infiltrating lymphocytes
|
WO2023147488A1
(en)
|
2022-01-28 |
2023-08-03 |
Iovance Biotherapeutics, Inc. |
Cytokine associated tumor infiltrating lymphocytes compositions and methods
|
WO2023196877A1
(en)
|
2022-04-06 |
2023-10-12 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
WO2023201369A1
(en)
|
2022-04-15 |
2023-10-19 |
Iovance Biotherapeutics, Inc. |
Til expansion processes using specific cytokine combinations and/or akti treatment
|
WO2023220608A1
(en)
|
2022-05-10 |
2023-11-16 |
Iovance Biotherapeutics, Inc. |
Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with an il-15r agonist
|
WO2024055018A1
(en)
|
2022-09-09 |
2024-03-14 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products using pd-1/tigit talen double knockdown
|
WO2024055017A1
(en)
|
2022-09-09 |
2024-03-14 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products using pd-1/tigit talen double knockdown
|